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T follicular helper (Tfh) cell is a unique T cell subset
specialized in promoting humoral immunity. B-cell
lymphoma 6 protein (Bcl6) has been identified as
an obligatory transcription factor in Tfh cells; how-
ever, the molecular mechanism underlying Bcl6
function remains largely unknown. Here, we defined
Bcl6 target genes in Tfh cells by analyzing genome-
wide Bcl6 occupancy together with transcriptome
profiling. With consensus sequences being different
from those in Th9, B cells, and macrophages, Bcl6
binding in Tfh cell was closely associated with a
decrease in 5-hydroxymethylcytosine (5hmC).
Importantly, Bcl6 promoted Tfh cell differentiation
through antagonizing IL-7R (CD127)/signal trans-
ducer and activator of transcription (STAT) 5 axis;
deletion of the Bcl6 gene in T cells resulted in
enhanced IL-7R-STAT5 signaling and substantial
expansion of CD127hi non-Tfh cells. Thus, our study
systemically examines Bcl6-controlled regulatory
networks and provides important insights into
Bcl6’s biological functions in Tfh cells.
INTRODUCTION
The hallmark of T-dependent humoral immunity is the formation
of germinal centers (GCs) in secondary lymphoid tissues (Ma-
cLennan, 1994; Nieuwenhuis and Opstelten, 1984; Victora and
Nussenzweig, 2012). GCs provide amilieu for B cell proliferation,
for their antibody affinity maturation and class switching, and for
plasma and memory B cell generation (Allen et al., 2007; Ma-
cLennan, 1994; Victora and Nussenzweig, 2012). GC generation
requires help from Tfh cells (Breitfeld et al., 2000; Crotty, 2011;
Dong et al., 2001; Kim et al., 2001; Vinuesa and Cyster, 2011).Cell RIn the past several years, tremendous efforts have been made
to define the genetic features of Tfh cells and the molecular
mechanisms underlying Tfh differentiation (Crotty, 2011; Liu
et al., 2013; Yu and Vinuesa, 2010). Transcription factor (TF)
Bcl6 expression was first found to be selectively upregulated in
Tfh cells; Bcl6-deficient T cells do not give rise to Tfh cells, and
constitutive expression of Bcl6 enhances Tfh cell differentiation
(Johnston et al., 2009; Nurieva et al., 2009; Yu et al., 2009). These
findings have recognized Bcl6 as an obligatory TF for Tfh devel-
opment and GC reactions (Johnston et al., 2009; Nurieva et al.,
2009; Yu et al., 2009), in line with T-bet for Th1, Gata3 for Th2,
and RORgt for Th17 (Zhu et al., 2010).
In addition to lineage-specific master TFs, T cell differentiation
is achieved by a complex network involving multiple TFs (Ciofani
et al., 2012; Zhu et al., 2010). Recently, Tfh signature geneCxcr5,
initially proposed as a target of Bcl6, is found to be directly regu-
lated by Achaete-Scute homolog 2 (Ascl2) (Liu et al., 2014). In
addition, TFs STAT3, STAT1, BATF, IRF4, C-Maf, and Ascl2 all
have been shown to positively regulate Tfh cell generation
(Crotty, 2011; Liu et al., 2013, 2014). In contrast, IL-2-induced
STAT5 signaling plays a negative role in Tfh cell development
(Ballesteros-Tato et al., 2012; Johnston et al., 2012; Nurieva
et al., 2012).
Bcl6 is a member of BTB-zinc-finger family protein and plays
critical roles in various cell types of the innate and adaptive im-
mune system (Chang et al., 1996; Dent et al., 1997; Shaffer
et al., 2000; Ye et al., 1993, 1997). Bcl6 was originally identified
in diffuse large B cell lymphomas (Ye et al., 1993). The proposed
functions of Bcl6 in B cells are to regulate the cell cycle and DNA
damage response and to suppress a host of signal pathways via
cooperation with SMRT, NCOR, and BCOR (Basso et al., 2010;
Crotty et al., 2010; Hatzi et al., 2013; Huang et al., 2013; Klein
and Dalla-Favera, 2008). Bcl6 also has important functions in
macrophage, in which it restricts Toll-like receptor (TLR)-
induced inflammatory reactions to re-establish quiescence by
cistrome-based antagonism of NF-kB (Barish et al., 2010,
2012). Chromatin immunoprecipitation coupled with deepeports 14, 1735–1747, February 23, 2016 ª2016 The Authors 1735
sequencing (ChIP-seq) analysis of Bcl6 and NF-kB bindings in
macrophage shows extensive co-localization between Bcl6
and NF-kB, suggesting a direct intersection between Bcl6
and NF-kB in a dynamic balance from activation to quiescence
(Barish et al., 2010).
Considering the molecular mechanisms underlying Bcl6 func-
tion in Tfh cells have been elusive, we assessed genome-wide
analysis of Bcl6-binding sites in primary Tfh cells, and we inte-
grated this dataset with the occupancy of multiple TFs, a global
map of epigenetic modifications, and transcriptome analysis
of Bcl6-responsive genes. We have identified Bcl6 as a
repressor against the IL-7R-STAT5-signaling cascade during
Tfh development.
RESULTS
Bcl6 Exhibits Unique Binding Motifs in Tfh Cells
To understand how Bcl6 mediates Tfh cell differentiation, we
performed ChIP-seq analysis for Bcl6 using in-vivo-generated
Tfh cells from Bcl6-RFP reporter mice as previously described
(Liu et al., 2012), with non-Tfh cells as a control. A total of
5,191 Bcl6-binding peaks were identified in Tfh cells
(Table S1). Most Bcl6-binding sites were localized to intron
(41%) and intergenic regions (46%), whereas 7% of them
were located in promoter regions (between 3 kb upstream and
downstream of the transcription start site [TSS]) (Figures 1A
and 1B). Previous studies have demonstrated that Bcl6 exerts
different roles in Th9, macrophage, and B cells (Barish et al.,
2010, 2012; Hatzi et al., 2013; Huang et al., 2013; Liao et al.,
2014). When we compared Bcl6-binding sites among T cells, B
cells, andmacrophages, we found that Bcl6 preferentially bound
to promoter regions in Th9 cells (promoter regions 18%, exons
6%, introns 38%, and intergenic 38%) and B cells (promoter
regions 16%, exons 9%, introns 40%, and intergenic 35%),
strikingly different from macrophages (promoter 3%, exons
3%, introns 42%, and intergenic 50%) and Tfh cells (promoter
regions 7%, exons 6%, introns 41%, and intergenic 46%) (Fig-
ure 1B; Figure S1A). Analysis of Bcl6-bound genes revealed
that only 230 genes were shared in all four types of cells (Fig-
ure 1C; Table S2), suggesting that Bcl6 regulates gene transcrip-
tion in a cell-type-specific manner. Not surprisingly, when
examining Bcl6-binding motifs, after exclusion of random repeat
motifs, we found that the top Bcl6-binding motifs in both Tfh
and Th9 cells contain classical Bcl6 consensus element
50-TTCNAGG(A/C)-30, which is different from that in macro-
phages and B cells (Figures 1D–1G). Further alignment of Bcl6-
binding consensus with Bcl6-occupied sequences confirmed
Bcl6-binding specificity in Tfh cells (Figure 1H). Notably, none
of the top three binding motifs in B cells contain the Bcl6 core
element. These data suggest divergent functions of Bcl6 among
T cells, macrophages, and B cells.
Bcl6 Binding Correlates with Decreased 5hmC
T cell fate specification is regulated by epigenetic modifications
of both histones and DNA (Lu et al., 2011; Tsagaratou et al.,
2014; Wei et al., 2009). To test whether the recruitment of Bcl6
correlates with histone modification changes, we used our previ-
ous ChIP-seq datasets for trimethylated histone H3 lysine 41736 Cell Reports 14, 1735–1747, February 23, 2016 ª2016 The Auth(H3K4me3) and trimethylated histone H3 lysine 27 (H3K27me3)
and compared them with Bcl6-bound areas (Liu et al., 2014).
As shown in Figures S1B and S1C, in both Tfh and naive CD4+
T cells, the intensity of H3K4me3 and H3K27me3 in Bcl6-occu-
pied regions remained very low and unchanged, suggesting Bcl6
binding is not associated with altered modifications of H3K4me3
or H3K27me3.
To further examine the association between Bcl6 and DNA
methylation, we performed methylated and hydroxymethylated
DNA immunoprecipitation (MeDIP/hMeDIP)-seq assays to map
genome-wide modification profiles of both 5mC and 5hmC in
naive CD4+ T and Tfh cells (Table S1). The resulting 5mC profile
defined 48,133 peaks in naive T cells and 33,063 peaks in Tfh
cells (Table S1). Importantly, no difference was found in 5mC
enrichment between Tfh and naive T cells in the 5,191 Bcl6-
bound areas (Figure 2A). In contrast, a great reduction of
5hmC was found in Tfh cells in Bcl6-binding sites as compared
to that in naive T cells (Figure 2B) as well as Th1, Th2, Th17,
and inducible regulatory T (iTreg) cells (Ichiyama et al., 2015;
Figure S1D). Analysis of genome-wide 5hmC reduction at
Bcl6-binding sites in Tfh cells defined 696 regions (distributed
among 645 gene loci) (Table S3). Among these, 98 genes were
transcriptionally controlled by Bcl6 and 15 were Bcl6-targeted
Tfh-specific genes (data not shown). Random examination of
sequencing tracks along mouse chromosome 11 illustrated
obvious colocalization of Bcl6 with 5hmC peaks at the
genome-wide level (Figures 2C and 2D). For example, at the
Stat5a and Stat3 gene loci, Bcl6 peaks only co-localized with
5hmC peaks in naive T cells due to the absence of 5hmC enrich-
ment in Tfh cells (Figure 2E). Furthermore, comparison of 5hmC
enrichment at Stat5a, Runx3, and Mgll gene loci among T cell
subsets confirmed the above statement (Figure S2A).
Our aforementioned analysis suggested that the reduction of
5hmC in Tfh cell is dependent on Bcl6. To test this hypothesis,
we isolated CD4+ CD44hi T cells from Bcl6fl/fl/CD4-Cre and con-
trol mice immunized with KLH/complete Freund’s adjuvant
(CFA), and we performed hMeDIP-PCR assays. As exemplified
at gene loci including Stat5a, Runx3, and Mgll, the levels of
5hmC in both wild-type (WT) and Bcl6-deficient non-Tfh cells
were enhanced (Figure S2B). To further elucidate themechanism
underlying Bcl6-dependent 5hmC reduction, we first measured
expression levels of methylcytosine dioxygenase Tet genes
(Ten-eleven-translocation proteins) including Tet1, Tet2, and
Tet3 in naive, Tfh, and non-Tfh cells, and we observed substan-
tial reduction of Tet1 expression in Tfh cells compared with Tet2
and Tet3 (Figure S2C). We then focused on functional analysis of
Tet1 by conducting ChIP assay in Bcl6-sufficient Tfh and non-
Tfh cells as well as Bcl6-deficient non-Tfh cells. As shown in
Figure S2D, Tet1 recruitment was increased at all three Stat5a,
Runx3, and Mgll loci in WT non-Tfh cells, as compared with
Tfh cells, and was even more significant in knockout (KO) non-
Tfh cells. Collectively, these data suggested a critical role of
Bcl6 in inhibiting Tet1 recruitment and 5hmC modification.
STAT5 and Bcl6 Share Binding Sequences
TFs including BATF, IRF4, c-Maf, and STAT3 have been shown
important in Tfh cells (Liu et al., 2013). We thus compared the
published data on the binding of BATF, IRF4, c-Maf, andors
Figure 1. Preferential Bcl6-Binding Motifs in Tfh, Th9, Macrophage, and B Cells
(A) Bcl6 binding in Tfh versus Non-Tfh cells. The tag density of Bcl6 binding around TSSs of all RefSeq (mm9) genes, uniquely mapped tags were summarized
in 20-bp windows. All window tag counts were normalized by the total number of bases in the windows and the total read number of the given sample. TSS,
transcription start site.
(B) Distribution of Bcl6-binding peaks in Tfh cells and distribution of the genetic features across the whole mouse genome (mm9) are shown.
(C) Venn diagram of genes bound by Bcl6 in Tfh, Th9, B cells, and macrophages. ChIP-seq data for Bcl6 binding in Th9 were derived from GEO: GSE41317-
GSM1234367 (Liao et al., 2014), macrophage were derived from GEO: GSE16723 (Barish et al., 2010), and Bcl6-binding in B cells was from GEO: GSE43350
(Huang et al., 2013).
(D) Classical Bcl6-binding consensus and Bcl6-binding motifs in Tfh cell are shown.
(E) Bcl6-binding motifs in Th9 cell (original sequence reads were reanalyzed and mapped to mouse genome mm9) are shown.
(F) Bcl6-binding motifs in macrophages are shown.
(G) Bcl6-binding motifs in B cells are shown.
(H) Alignment of Bcl6-binding consensus on overall ChIP-seq signal in Tfh and non-Tfh cells is shown.
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Figure 2. Bcl6 Recruitment to Target Genes in Tfh Cells Reduced the Level of 5-hydroxymethylcytosine
(A) At Bcl6-bound regions, 5-methylcytosine (5mC) enrichments were compared between naive T and Tfh cells.
(B) At Bcl6-bound regions, 5-hydroxymethylcytosine (5hmC) enrichments were compared between naive T and Tfh cells.
(C) Classical Bcl6-binding consensus, 5hmC-enrichment motif in naive T cells, and Bcl6-binding motif in Tfh cells are shown.
(D) ChIP-seq binding tracks for 5mC, 5hmC, and Bcl6 at selected chromosome 11 regions in naive and Tfh cells. Green frames represent the co-localization of
peaks.
(E) ChIP-seq binding peaks for 5hmC and Bcl6 at selected Stat5a and Stat3 gene loci in naive and Tfh cells. Green frames represent the co-localization of peaks.STAT3 (Ciofani et al., 2012) to Bcl6 data. Motif analysis of Bcl6
binding revealed that Bcl6 did not share consensus binding
motifs with BATF, IRF4, c-Maf, or STAT3 (Figure 1D; data not
shown), although a small number of Bcl6-binding sites in Tfh
cells could be the direct binding sites of BATF, IRF4, C-Maf, or
STAT3 in Th17 cells (Table S4). These observations suggest
Bcl6 may function together with BATF, IRF4, C-Maf, or STAT3
in shaping Tfh cell polarization.
Further motif analysis showed that the core element in Bcl6-
binding consensus in Tfh cells was almost the same as STAT5-
binding motif, except for one nucleotide difference (Figure 3A).
Because STAT5 inhibits Tfh cell generation (Johnston et al.,
2012; Nurieva et al., 2012) and Tfh cell was shown to lack
STAT5 signaling (Johnston et al., 2012), our observation impli-
cated potential competition between Bcl6 and STAT5 in regu-
lating Tfh cell differentiation. We then examined and compared
Bcl6-binding sites in Tfh cells and STAT5-binding peaks in
Th17 cells at the genome-wide level (Yang et al., 2011), and
we found that they potentially share a great amount of binding
sites, among which the majority (proximal promoter 21% +
exon 15% + intron 38%) was located in gene bodies (Figure 3B)
and a total of 424 genes could be co-regulated by Bcl6 and1738 Cell Reports 14, 1735–1747, February 23, 2016 ª2016 The AuthSTAT5 (Table S5). As exemplified in Figures S3A–S3D and Fig-
ure 3C, although co-occupancy of STAT5 and Bcl6 was barely
found in Th-related signature gene loci, strong co-localization
was seen in Socs2, Il7r, and Tcf7. To confirm our ChIP-seq
data, we conducted ChIP-PCR with anti-Bcl6, anti-p-STAT5a,
and IgG control antibody. In comparison with control-IgG enrich-
ment, p-STAT5 was observed bound to Il7r, Socs2, and Tcf7 re-
gions in IL-2- or IL-7-treated non-Tfh cells, while Bcl6 bound to
the same location in Tfh cells (Figure S4). Thus, these findings
implicate reciprocal roles of Bcl6 and STAT5 in Tfh versus non-
Tfh cell polarization, respectively.
Transcriptional Changes Mediated by Bcl6 in Tfh Cells
From our published microarray data obtained using Bcl6-RFP
reporter mice (Liu et al., 2012), we previously have identified
1,100 Tfh-relevant genes, among which there were more
downregulated genes than upregulated ones (left panel, Figures
4A and 4B). To further define genes that are transcriptionally
regulated by Bcl6, we transferred WT or Bcl6-deficient OT-II
cells into congenic recipient mice. Then, 4 days after ovalbumin
(OVA)/CFA immunization, we harvested CXCR5+ donor cells (as
we had reported, Bcl6 deficiency did not ameliorate CXCR5ors
Figure 3. Preferential Bcl6 Binding to STAT5 Motifs in T Cells
MEME-ChIP (http://meme-suite.org/tools/meme-chip) default parameters were applied to analyze the consensus sequences within Bcl6-binding sites in Tfh
cells and STAT5-binding sites in Th17 cells (Yang et al., 2011). The binding sites of both Bcl6 and Stat5 were first defined using the SICER V1.1 program. A binding
site is defined as one or several consecutive windows of 200 bp of the genome where a significant enrichment of sequencing reads against the background
appears. If any part of one TF-binding site overlaps with the other one, it is defined as the overlay of the two binding sites.
(A) Comparison of Bcl6-binding motifs in Tfh cells with STAT5-binding motifs in T cells. ChIP-seq data for STAT5 binding in T cells was derived from GEO:
GSE26553-GSM652878 (Yang et al., 2011).
(B) Distribution of Bcl6/STAT5 co-occupancies in proximal promoter, exon, intron, and intergenic regions is shown.
(C) Bcl6- and STAT5-colocalized peaks located at gene loci including Socs2, Il7r, and Tcf7 are shown.expression at this early stage) and then performed RNA
sequencing (RNA-seq) assays (data not shown). RNA-seq
analysis revealed that Bcl6 played a pivotal role in regulating
Tfh-related transcriptome and that the absence of Bcl6 altered
Tfh-gene profiling dramatically (middle panel, Figures 4A and
4B). Additionally, we conducted RNA-seq analysis on T cells in-
fected in vitro with Bcl6- or vector-overexpressing retrovirus.
Bcl6 was sufficient globally in regulating the gene expression
landscape, although the fold changes for each gene were rela-
tively modest (right panel, Figures 4A and 4B). These data clearly
indicate a critical transcriptional regulation by Bcl6.
After combining three datasets, ChIP-seq, RNA-seq of WT
and Bcl6 mutant OT-II cells in vivo, and Tfh-relevant genes
from microarray, we identified a total number of 74 genes that
were directly regulated by Bcl6 in Tfh cells (Figure 4C; Table
S6). Among these Bcl6-target Tfh-specific genes, 26 were upre-
gulated and 48 were downregulated by Bcl6 (Figure 4D; Table
S5). Functional analysis and comparison of these genes with
Ascl2 targets (44 genes) further confirmed our previous conclu-
sion that Bcl6 and Ascl2 play distinct roles during Tfh differenti-
ation (Liu et al., 2014). Bcl6 and Ascl2 co-regulate only four
genes, Slc9a9, Tcf7, Thop1, and Lif, among which TF TCF-1
(Tcf7) was demonstrated as a critical regulator for Tfh cell gener-
ation in two recent studies (Figure 4D; Choi et al., 2015; Kubo,
2015; Xu et al., 2015). Bcl6 target genes in Tfh cells were more
likely involved in cell death and survival, cell cycle and growth,
etc., while Ascl2 target genes were associated with cell differen-
tiation, migration, and effector function (Figures S5A–S5D). OfCell Rthe 74 Tfh-specific Bcl6-target genes, the top 15 most upregu-
lated and downregulated ones are listed in Figure S6A. Interest-
ingly, Il13 gene was most repressed by Bcl6, consistent with the
excessive Th2-associated inflammation in Bcl6 mutant mice (Ye
et al., 1997). Notably, Th17-related Ahr and Fosl2 were among
the top suppressed genes (Ciofani et al., 2012; Veldhoen et al.,
2008), indicating an indirect role of Bcl6 in shaping the Th17 pro-
gram. Interestingly, a reduction of 5hmC level also was found at
the center of Bcl6-binding sites located to Tfh-specific Bcl6-
target genes in Tfh cells as compared to that in naive T cells (Fig-
ure S6B). In the list of Bcl6-upregulated genes, Mxd4, encoded
by a basic helix-loop-helix-leucine zipper family member, was
able to inhibit IL-2 expression in activated T cells (Figure S6C).
Bcl6-Mediated Regulatory Modules in Tfh Cells
If Tfh-relevant genes were not taken into consideration, then the
combination of Bcl6-regulated genes and Bcl6-bound genes
generated a list of 382 putative Bcl6-target genes (Figure 4C; Ta-
ble S7), indicating that, beyond regulating 74 Tfh-specific genes,
Bcl6 exerts a broader biological function in Tfh cell physiology.
Pathway analysis of 382 genes using the Database for Annota-
tion, Visualization and Integrated Discovery v6.7 (DAVID, Huang
da et al., 2009) revealed that Bcl6-target genes were strongly
associated with cellular activation and maintenance, signal
transduction, cell adherence, and metabolism, and they were
specifically enriched for genes involved in calcium and the
MAPK-signaling pathway, JAK-STAT signal transduction, cyto-
kine/cytokine receptors, and purine metabolism (Figure 5A).eports 14, 1735–1747, February 23, 2016 ª2016 The Authors 1739
Figure 4. Bcl6-Dependent Transcriptional Regulation of Tfh-Relevant Genes
(A) Heatmap of 1,100 Tfh-relevant genes regulated in CXCR5hi Bcl6-RFPhi Tfh and CXCR5lo Bcl6-RFPlo non-Tfh cells (Student’s t test on Tfh versus
non-Tfh microarray data analysis and identified 1,100 genes with at least 2-fold difference), heatmap of 1,100 TFH-relevant genes (p < 0.05, Student’s t test;
fold change > 2), microarray accession GEO: GSE40068 (Liu et al., 2012), left column), donor-derived CXCR5+ Bcl6+/+ OT-II and CXCR5+ Bcl6/ OT-II cells
(RNA-seq, middle column), and Bcl6-RV-GFP- or control vector-transduced T cells cultured under Th0 condition for 4 days (RNA-seq, right column). The color
coding applies to gene expression level (log2) with 0 as median.
(B) Scatterplot shows the average signal of Tfh versus non-Tfh cells gene expression microarray data, day 3-donor-derived CXCR5+ Bcl6+/+ versus CXCR5+
Bcl6/ OT-II cells gene expression RNA-seq data, and Bcl6-RV-GFP+ versus Empty-RV-GFP+ T cell gene expression RNA-seq data.
(C) Venn diagram shows Tfh-relevant genes, Bcl6-regulated genes, and Bcl6-bound genes.
(D) Bcl6- and Ascl2- (GEO: GSE52840, Liu et al., 2014) targeted Tfh-specific genes. Green represents downregulation of gene expression; red represents
upregulation of gene expression.Importantly the top two upstream regulators of Bcl6-targeted
genes, predicted using Ingenuity Systems, were STAT5A and
Bcl6, followed by other regulators including IL-7, IL-4, and
IL-21 (Figure 5B), suggesting again that Bcl6 and STAT5 may
cooperate in the regulation of Tfh cell polarization and function.
Taken together, validations and classification of Bcl6-target
genes have established a unique Bcl6-centered network that
orchestrates Tfh cell differentiation.
Bcl6 Suppresses IL-7R Expression during Tfh Cell
Generation
In the above analysis, IL-7R was predicted as the direct down-
stream target of five signaling pathways during Tfh cell develop-
ment, including Bcl6- and STAT5-related pathways (Figure 5B).
RNA-seq of Bcl6 mutant OT-II cells together with Bcl6 ChIP-seq
data defined IL-7R as one of the most repressed Tfh-relevant
genes by Bcl6 (Figures S6A, S6D, and S6E). Moreover, ectopic
expression of Bcl6 in activated T cells in vitro strongly inhibited1740 Cell Reports 14, 1735–1747, February 23, 2016 ª2016 The AuthIL-7R expression (Figure S6D). We thus reasoned that Bcl6
suppression of IL-7R might be important in Tfh cell differentia-
tion. We then examined IL-7R protein and Bcl6 expression
during Tfh ontogeny in vivo by transferring naive Bcl6-RFP/
OT-II cell into congenic recipient mice, followed by OVA/CFA
immunization.
As shown in Figures 6A and 6B, donor-derived OT-II cells
gradually gained expression of Bcl6-RFP, while CD127 (IL-7R)
expression was reduced. Of note, the expression levels of
CD127 in Bcl6-RFP+ Tfh cells were extremely low. To confirm
the observation, we measured the expression of CD127 in
donor-derived OT-II cells from congenic mice immunized with
OVA/CFA subcutaneously (s.c.), and we found that CD127
(IL-7R) expression was inversely correlated with all three
classical Tfh cell markers, PD-1, CXCR5, and Bcl6 (Figures
S6F and S6G). To understand whether Bcl6 is necessary for re-
pressing IL-7R gene expression, we generated a new strain of
Bcl6 conditional KO mice and bred them with CD4-Cre miceors
Figure 5. Bcl6-Mediated Regulatory
Modules for Tfh Cell Development
(A) Kyoto Encyclopedia Gene and Genome
(KEGG) pathway analysis of Bcl6 directly regu-
lated genes using DAVID. A heatmap of normal-
ized gene expression levels is shown. Blue
represents downregulation of gene expression
and red represents upregulation of gene expres-
sion, with 1 as the median.
(B) Upstream regulators prediction was performed
using the ingenuity analysis tool (IPA) on Bcl6-
target genes with the value p < 0.05.(Figure S7A). These mice were immunized with keyhole limpet
hemocyanin (KLH)/CFA for 7 days, with Bcl6+/+/CD4-Cre litter-
mate as controls. Strikingly, the disruption of the Bcl6 gene in
T cells resulted in all of CD4+CD44+ activated T cells becoming
CD127hi cells (Figure 6C). Therefore, these results suggested
that IL-7R could be a novel marker for non-Tfh cells and that
Bcl6-dependent IL-7R repressionmight be critical for Tfh cell dif-
ferentiation. To further test this idea, we sorted two populations
of CD4+CD44hi CD127hiPD1lo and CD4+CD44hi CD127loPD1hi
cells from KLH/CFA-immunized WT mice and quantified mRNA
expression of Tfh-related genes (Figures 6C and 6D). Cxcr5,
Bcl6, Ascl2, and Tcf7 were all highly expressed in CD127loPD1hi
Tfh cells, while Prdm1, Tbx21, Gata3, and Rorc were preferen-
tially expressed in CD127hiPD1lo non-Tfh cells (Figure 6D).
IL-7R/STAT5 Axis Negatively Regulates Tfh Cells
Our aforementioned results showed that IL-7R expression is
inversely correlated with Tfh commitment; we hypothesized
that IL-7 signaling might inhibit Tfh cell generation. To directly
test that, we performed gain- and loss-of-function experiments.Cell Reports 14, 1735–1747, FAs shown in Figure 7A, when naive OT-II
cells were transferred into congenic
mice that were subsequently immunized
with OVA/CFA together with anti-IL-7R
or an isotype control antibody, IL-7R
blockade did not impair OT-II cell expan-
sion (Figure S7B), but did enhance the
development of Tfh cell (Figure 7B).
Accordingly, GC reaction also was
elevated in anti-IL-7R-treated mice
(Figure 7C).
Next, we transferred Il7r- or vector-
transduced OT-II cells into congenic
mice followed with s.c. OVA/CFA
immunization for 8 days. Although the
expansion of IL-7R-overexpressing
OT-II was slightly increased in numbers
(Figure S7C), ectopic expression of
IL-7R strongly inhibited Tfh cell differenti-
ation (Figure 7D). Together, these data
demonstrated that IL-7R plays a negative
role in Tfh cell differentiation.
As documented above, IL-7R nega-
tively regulates Tfh differentiation andBcl6 functions to suppress IL-7R expression during Tfh cell dif-
ferentiation, so we asked whether Bcl6 also antagonizes IL-7R-
downstream-STAT5 activation in the process of Tfh
differentiation. Bcl6+/+/CD4-Cre and Bcl6fl/fl/CD4-Cre mice
were immunized with KLH protein emulsified with CFA. Then,
7 days after immunization, Tfh and non-Tfh cells were examined.
As expected, CXCR5hiPD1hi Tfh cells were completely abolished
in Bcl6fl/fl/CD4-Cre mice (Figure 7E). When three populations of
cells, CXCR5hi PD1hi Tfh and CXCR5lo PD1lo non-Tfh cells from
Bcl6+/+/CD4-Cre mice and CXCR5lo PD1lo non-Tfh cells from
Bcl6fl/fl/CD4-Cre mice, were sorted and stimulated by either
anti-CD3 or IL-7, an assessment of STAT5 activation was con-
ducted. Although STAT5 in Tfh cells remained non-phosphory-
lated, Bcl6 deficiency in non-Tfh cells led to strongly enhanced
STAT5 phosphorylation (Figure 7F). The elevated STAT5 activa-
tion in Bcl6-deficient T cells was, in part, associated with the in-
crease of Il7r and Stat5a mRNA expression (Figures S7D and
S7E). These results collectively demonstrated that Bcl6 func-
tions to suppress the IL-7R/STAT5-signaling axis in promoting
Tfh cell differentiation.ebruary 23, 2016 ª2016 The Authors 1741
Figure 6. Reciprocal Expression of IL-7R and Bcl6 during Differentiation of Activated CD4+ T Cells into Distinct T Cell Subsets
(A and B) Naive Bcl6-RFP/OT-II CD4+ T cells were transferred into naive congenic CD45.1mice, whichwere subsequently immunizedwith OVA/CFA s.c. Data are
representative of two independent experiments. (A) Experimental design for measuring Bcl6-RFP and IL-7R expression in donor-derived Bcl6-RFP/OT-II cells
in vivo is shown. (B) Flow cytometry analysis of CD127 and Bcl6-RFP expression in donor-derived Bcl6-RFP/OT-II cell in a time-dependent manner is shown.
(C) Flow cytometry measurement of CD127 and PD1 expression on activated CD44+ CD4+ T cell in draining LNs fromBcl6+/+/CD4-Cre andBcl6fl/fl/CD4-Cre mice
immunized with KLH/CFA s.c. for 8 days. Data are representative of two independent experiments.
(D) Two populations of CD127hi PD1lo and CD127lo PD1hi were sorted from CD44+ CD4+ T cell pools in dLNs of Bcl6+/+/CD4-Cre mice immunized with KLH
emulsified in CFA s.c. qRT-PCRmeasurement ofCxcr5, Bcl6, Ascl2, Tcf7, Prdm1, Tbx21,Gata3, and RorcmRNA expression in sorted two populations of cells is
shown.
Data are representative of two independent experiments. Bar graph is displayed as mean ± SD (n = 3 per group).DISCUSSION
Despite the discovery of Bcl6 as the core TF for Tfh cells (Can-
nons et al., 2013; Crotty, 2011), little was known as to how
Bcl6 directs the development and function of Tfh cells. Here
we built a Bcl6-dependent transcriptional network by combining
the gene expression profiling and ChIP-seq datasets and by
further validating the role of IL-7R signaling during Tfh cell
response. Our data demonstrate that Bcl6 promoted Tfh cell
generation, at least in part through antagonizing the IL-7R/
STAT5 axis. In comparison with published studies on Bcl6 func-
tion in multiple cell types (Barish et al., 2010, 2012; Basso et al.,
2010; Ci et al., 2009; Huang et al., 2013; Liao et al., 2014), our
findings highlighting the functional specificity of Bcl6 in mouse
Tfh cell were supported by preferential DNA-binding motifs
and distinct sets of target genes.
Bcl6 functions critically in various types of cells. Bcl6-deficient
mice develop immune inflammation in multiple organs charac-
terized with deregulated innate immunity, infiltration of eosino-
phil, and Th2-mediated hyperimmune responses, but have a
defective GC reaction as a result of failed formation of both Tfh1742 Cell Reports 14, 1735–1747, February 23, 2016 ª2016 The Authand GC B cells (Johnston et al., 2009; Nurieva et al., 2009;
Phan and Dalla-Favera, 2004; Ye et al., 1997; Yu et al., 2009).
In a recent study, knockin point mutation in Bcl6 BTB domain
dissociates the binding of BTB domain with its co-repressors
NCOR, SMRT, and BCOR, manifested as the failure of GC B
cell formation, whereas Tfh cells andmacrophages remain intrin-
sically unaffected by this mutation (Huang et al., 2013). What
distinguished this selectivity remained unclear. Our present
study analyzing global binding profiles of Bcl6 in Tfh cells, Th9
cells, B cells, and macrophages provided critical insights into
the functional diversity of Bcl6. In both mouse Tfh and Th9 cells,
Bcl6 bound preferentially to consensus sequences containing
classical Bcl6-binding motifs, which was strikingly different
from that in B cells, although to a lesser extent in macrophages.
For instance, Bcl6 is able to bind to Prdm1 (Blimp1) gene locus
in B cell and human T cell to inhibit its expression (Crotty et al.,
2010; Hatzi et al., 2015), while no Bcl6 binding was found at
the Prdm1 locus in mouse Tfh (Figure S3A) or Th9 cells (data
not shown). Among Bcl6-target genes in Tfh cells, many of
them were involved in fundamental biological activities, such
as calcium-signaling pathway (Cacna1d, Cacna1b, Cacna1i,ors
Figure 7. Bcl6 Protected Tfh Cells from Negative Regulation of IL-7R/STAT5 Axis
(A) Experimental design for testing IL-7R function in vivo is shown.
(B and C) Naive OT-II cells were adoptively transferred into naive congenic mice, followed with s.c. OVA/CFA immunization. At day 3 after immunization,
anti-IL-7R or isotype control antibodies (200 mg/mouse) were injected s.c. into mice, respectively. Data are representative of two independent experiments (n = 3
per group). (B) At day 8 post-immunization, flow cytometry analysis of donor-derived cells in dLNs with CXCR5 and Bcl6 staining. Bar graph is displayed as
mean ± SD (n = 4 per group). (C) GC B cells (GL-7hi Fashi) in recipient mice. Bar graph is displayed as mean ± SD (n = 4 per group).
(D) Il7r-RV-GFP- or control vector-transduced OT-II cells were adoptively transferred into naive congenic mice, respectively, followed with s.c. OVA/CFA im-
munization for 7 days. Flow cytometry analysis of donor-derived cells from dLNs with CXCR5 and PD1 staining is shown. Data are representative of two in-
dependent experiments. Bar graph is displayed as mean ± SD (n = 4 per group).
(E and F) Bcl6+/+/CD4-Cre and Bcl6fl/fl/CD4-Cre mice were s.c. immunized with KLH/CFA. Data are representative of two independent experiments (n = 4 per
group). (E) At day 8, flow cytometry analysis of Tfh and Non-Tfh cells from dLNs with staining CXCR5 and PD1 is shown. (F) Three populations of cells, CD4+
CD44hi CXCR5hi PD1hi Tfh cells from Bcl6+/+/CD4-Cre mice and CD4+ CD44hi CXCR5lo PD1lo non-Tfh cells from both Bcl6+/+/CD4-Cre and Bcl6fl/fl/CD4-Cre
mice, were sorted, re-stimulated with plate-coated anti-CD3 or IL-7, and subject to intracellular measurement of STAT5 phosphorylation by flow cytometry.
Data are representative of two independent experiments.Itpr2, and Ppp3ca), cell adherence junction (Insr, Igf1r, Ctnnd1,
Ptprj, and Ctnna1), and purine metabolism (Pdeba, Ampd2,
Pde4a, Pfas, and Fhit). Of note, despite recent findings that TF
TCF-1 (Tcf-7) regulates Bcl6 expression in Tfh cell (Hatzi et al.,Cell R2015; Kubo, 2015; Xu et al., 2015), our ChIP-seq data demon-
strated that TCF-1 was a common downstream target of both
Bcl6 and Ascl2 (Figure 4D), indicating a complex interaction of
TFs in the course of Tfh cell response. Also, Bcl6 was able toeports 14, 1735–1747, February 23, 2016 ª2016 The Authors 1743
bind to Il13 locus in T cells and to repress its expression at a fold
magnitude of hundreds. This finding for the first time provided
direct explanation for the elevation of Th2-mediated immunity
in Bcl6-null mice (Ye et al., 1997). Bcl6 restrains inflammatory
responses in macrophage through directly counteracting
TLR4-induced transcriptome, NF-kB-cistromes, and histone
acetylation (Barish et al., 2010). In Tfh cells, however, Bcl6 bind-
ing to gene loci was associated with decreased Tet1 recruitment
specifically, and Bcl6-binding regions appear to have repressive
epigenetic modification with low levels of 5hmC.
It has been described that Bcl6 acted as the master regulator
for Tfh cell commitment through repression of other T cell line-
ages, including Th1, Th2, and Th17 (Johnston et al., 2009; Nur-
ieva et al., 2009; Yu et al., 2009). Bcl6 deficiency results in
massive enhancement of inflammatory cytokine production in
T cells (Figures 4A and 4B). However, surprisingly few of Bcl6-
binding sites were observed in Th signature gene loci, which
raised the question of how Bcl6 repressed Th-relevent genes.
Our observation that a substantial amount of STAT5a peaks
were enriched on the majority of these genes leaves us a hint
that Bcl6 might restrain Th cell via controlling STAT5 activation
(Figure S3). Indeed, our genome-wide expression profiling and
ChIP-seq analysis showed that Bcl6 suppresses both IL-7R (Fig-
ures S4 and S6) and STAT5 (Figures S2A and S7E) expression;
Bcl6 also played a role blocking IL-2-triggered STAT5 activation
through elevation of Mxd4 (Figures S6A and S6C). Accordingly,
Bcl6-mediated IL-2/IL-7-signaling inhibition in Tfh cells led to
the silencing of STAT5 phosphorylation. Moreover, our results
showed that Bcl6 and STAT5 bound reciprocally to overlapping
sites in many common genes in Tfh and non-Tfh cells, respec-
tively (Figure 3C; Figure S4). Collectively, opposition between
Bcl6 and STAT5 offered a mechanistic basis for bifurcating Tfh
versus non-Tfh cell development.
IL-7R is expressed on naive and memory T cells for their ho-
meostatic survival (Kaech et al., 2002, 2003; Li et al., 2003;
Schluns et al., 2000). TCR engagement in activated T cell in-
duces IL-7R downregulation via IL-2-mediated signaling
pathway (Xue et al., 2002). Nonetheless, because Tfh cells lack
IL-2 receptors, including IL-2Ra and IL-2Rb (Johnston et al.,
2012; Liu et al., 2014), repression of IL-7R by Bcl6 turns out to
be a dominant pathway, which prevents Tfh differentiation
from STAT5-mediated regulation. After full commitment, Tfh
memory precursor cells are proposed to gain IL-7R expression
by reducing Bcl6 and prepare for memory generation (Kitano
et al., 2011). Given that Bcl6 is necessary for the maintenance
of long-lived memory T cell (Ichii et al., 2002), further research
is thus needed to clarify this discrepancy.
A recent study has identified genome-wide Bcl6-binding
profiles in human tonsil Tfh cells (Hatzi et al., 2015). Analysis of
their human data reached several consistent conclusions with
our mouse Bcl6-binding data. For example, Bcl6 did not directly
regulate expression of signature genes such as Rorc and Il-4;
IL-7R expression was substantially suppressed by Bcl6; and
STAT-binding sites were enriched among Bcl6-binding sites.
However, a significant difference in Bcl6-binding profiles existed
between mouse and human Tfh cells. Bcl6 was shown to directly
bind 8,523 genomic loci and interact physically with AP-1 in
human tonsil Tfh cells (Hatzi et al., 2015), while only 5,191 Bcl6-1744 Cell Reports 14, 1735–1747, February 23, 2016 ª2016 The Authbinding sites were identified in CXCR5hi Bcl6-RFPhi Tfh cells
sorted from mouse peripheral lymphocyte pools. In addition, we
did not find an enrichment of AP-1-binding sites among mouse
Bcl6-binding sites. It is well known that Bcl6 functions through
cooperating with different partners in different cell types. It is un-
derstandable that the Bcl6-binding profiles in human tonsil
CD45RO+ CD4+ CXCR5hi PD1hi T cells could be different from
mouse peripheral CXCR5hi Bcl6+ cells. In addition, the discrep-
ancies of Bcl6-binding profiles might be caused by the fact that
transcriptional regulation of mouse Tfh cell differs from that of
human Tfh cell. For example, human, but not mouse, naive CD4+
T cell can be polarized into Tfh cells by either TGF-b/IL-12 or
TGF-b/IL-23 (SMAD2/STAT4/STAT6) (Schmitt et al., 2013, 2014).
In summary, by combining and comparing transcriptome and
ChIP-seq data from T cell, B cell, and macrophage, we have
identified Tfh-specific Bcl6-mediated regulatory modules,
among which some key components were tested by gain- or
loss-of-function assays. Therefore, our study has great implica-
tions for vaccine development and clinical treatment of anti-
body-mediated autoimmune disorders.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6, CD4-Cre, OT-II, Rosa26-FLP1, and B6SJL mice were from Jackson
ImmunoResearch Laboratories. Bcl6-RFP and Bcl6/ mice were maintained
as previously described (Liu et al., 2012; Nurieva et al., 2009). The Bcl6fl/flmice
were created by homologous recombination. Bcl6fl/fl mice were bred with
CD4-Cre mice to generate Bcl6fl/fl/CD4-Cre and control mice Bcl6+/+/CD4-
Cre. Mice were maintained in specific pathogen-free animal facility, used in
accordance with governmental and institutional guidelines for animal welfare
and approved by the Institutional Animal Care and Use Committee, Tsinghua
University. Age- and sex-matched donor or recipient mice were selected and
included in different groups, typically 3–5 mice per group.
Immunization and Flow Cytometry
Mice and their WT controls (6–8 weeks old; 3–5 mice per group) were immu-
nized with KLH or OVA (0.5 mg/ml) emulsified in CFA (0.5 mg/ml) s.c. (100 ml
eachmouse). Thymic, splenic, and lymph node cells were stained with fluores-
cence-labeled antibodies and analyzed with a Fortesa and Flowjo. Intracellular
staining was carried out with kits from eBioscience.
Retroviral Transduction
Naive CD4+CD25CD44lowCD62Lhigh T cells from Bcl6//OT-II, OT-II, or
C57BL6 mice were sorted via fluorescence-activated cell sorting (FACS) and
activated with plate-bound anti-CD3e (clone, 2C11) and anti-CD28 (clone,
37.51) under neutral conditions. Then, 24 hr after activation, cells were infected
by retroviruses Il7r-RV-GFP, Mxd4-RV-GFP, Bcl6-RV-GFP, or control empty
vector (Empty-RV-GFP). Next, 2 days after infection, GFP cells were sorted
via FACS for adoptive transfer or followed by re-stimulation with pre-coated
anti-CD3e. Cell transfer numbers were 1–4 3 105 for GFP+ T cells.
RNA-Seq
Total cellular RNA was extracted from sorted donor-derived CXCR5+ Bcl6//
OT-II-, CXCR5+ Bcl6+/+/OT-II-, Bcl6-RV-GFP+-, or Empty-RV-GFP+- infected
cells with TRIzol reagent (Invitrogen). Sequence reads were obtained using
the SOLiD v4 sequencing platform in order to generate a gene expression pro-
file. To identify differential expression, the RNA-seq reads were successfully
mapped to mouse genome without quality problems. Read counts were
normalized, fold changes were calculated for all possible comparisons, and
a 2-fold cutoff was used to select genes with expression changes. A padding
procedure was used to calculate fold changes in avoidance of blowout due to
near zero counts.ors
ChIP-Seq, MeDIP, and hMeDIP
ChIP-seq was performed as described previously (Wei et al., 2009). Briefly, in-
vivo-generated CXCR5hi Bcl6-RFPhi Tfh and CXCR5lo Bcl6-RFPlo Non-Tfh
cells were sorted from Bcl6-RFP mice immunized with KLH/CFA, stimulated
with plate-coated anti-CD3e, and fixed by 1% paraformaldehyde, and fol-
lowed with digestion with Mnase cocktail (Active Motif). Chromatin from 2 3
106 cells was used for each ChIP experiment. Antibody against Bcl6 pAb
(SC858 (N-3), Santa Cruz Biotechnology) was used. The MeDIP and hMeDIP
assays were performed as previously described (Ichiyama et al., 2015; Vucic
et al., 2009). In brief, the genomic DNA from naive CD4+ T cells and Tfh cells
was purified and sonicated. DNA fragments (4 mg) were denatured and incu-
bated with antibodies against 5mC (Eurogentec), 5hmC (Active Motif), or con-
trol IgG at 4C overnight. Antibody-DNA complexes were captured by protein
A agarose/Salmon sperm DNA. The immunoprecipitated DNA was purified
and subjected to sequencing library preparation. All sequencing libraries
were prepared using the TruSeq ChIP Sample Prep Kit (Illumina) according
to the manufacturer’s protocol. The DNA libraries were then sequenced with
Illumina HiSeq 2500 at the Zhongshan Ophthalmic Center core facility.
Sequenced reads of 50 bp were obtained using the CASAVA 1.8.2 package
(Illumina). All reads were mapped to the mouse genome mm9 and those
uniquely mapped reads were subjected to further peak identification process.
SICER_V1.1 (Zang et al., 2009) was used to identify significant peaks (false dis-
covery rate [FDR] of 1%) with input DNA (ChIP-seq) or IgG IP (MeDIP-seq) as
the controls. Outputs of the peak files were converted to browser-extensible
data (BED) files and viewed with UCSC genome browser. The MEME-ChIP
(Machanick and Bailey, 2011) was used to perform the consensus binding
motif analysis for Bcl6. To calculate the tag density of Bcl6 binding or epige-
netic modifications around TSSs or the centers of Bcl6-binding sites, uniquely
mapped tags were summarized in 20-bp windows, and all window tag counts
were normalized by the total number of bases in thewindows and the total read
number of the given sample.
Real-Time RT-PCR Analysis
Total RNA was extracted with Trizol reagent (Invitrogen). Oligo (dT) and MMLV
reverse transcriptase (Invitrogen) were used to generate cDNA. Gene expres-
sions were examined by iQ SYBR real-time kit (Bio-Rad). The data were
normalized to a reference gene beta-actin. The primer pairs for real-time
RT-PCR analysis of Bcl6, Ascl2, CXCR5, Blimp1, Gata3, T-bet, RORg, Tet1,
Tet2, and Tet3 were previously described (Ichiyama et al., 2015; Liu et al.,
2012). The primer pair for detection of mouse Tcf7 is as follows: forward,
50-GGGAAAAACATCAAGAATCCACCA-30; reverse, 50-CTGGGCTAGCAAGC
AGTTCT-30.
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